Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Trading Company
Tel: 86--1829 2989 553
Mobile:
Tel: 86--1829 2989 553
Fax:
URL: http://www.db-biotech.com
Province/state: shaanxi
City: xi'an
Street: No.99 Road, Xi'an, China
MaxCard:
CAS NO.2023788-19-2
99%(1-25)Gram
Q1: Are you a manufacturer
Answer: Yes, we are factory founded on 2012.
Q2: How to contact with us
Click "contact supplier" And then send us message the product you interest in, you will get reply within 12 hours.
Q3:Which kind of payment terms do you accept
For small order,you can pay by T/T, or Paypal,nomal order by T/T to our company account
Q4:Can you give me a discount price
Surely,It depend on your qty
Q5:How can i get a sample
free samples is available,but freight charges will be at your account and the charges will be return to you or deduct from your order in the future.
Q6: How to confirm the Product Quality before placing orders
A:You can get free samples for some products,you only need to pay the shipping cost or arrange a courier to us and take the samples. You can send us your product specifications and requests,we will manufacture the products according to your requests.
Q7:How do you treat quality complaint
A:First of all, our quality control will reduce the quality problem to near zero. If there is a real quality problem caused by us, we will send you free goods for replacement or refund your loss.
Name Product:
Tirzepatide
Molecular structural formula
Product 931-184
CAS Number:
2023788-19-2
Molecular Formula:
C225H348N48O68
Molecular Weight:
four thousand eight hundred and thirteen point four five
Indications:
Obesity, type ll diabetes.
Pharmacology:
GIP is a hormone that can supplement the action of GLP-1 receptor agonists. In preclinical models, GIP has been shown to reduce food intake and increase energy expenditure, leading to weight loss, and when used in combination with GLP-1 receptor agonists, may have a greater impact on metabolic dysregulation markers such as weight, glucose, and lipids.
Route of administration
subcutaneous injection
Taboo Taboo:
Tirzepatide is not suitable for patients with medullary thyroid cancer
Amino Acid Sequence:
Tyr- {Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-lle-{Aib}Leu-Asp-Lys-lle-Ala-GIn- {diacid-C20-γ-Glu-(AEEA)2-Lys}-Ala-Phe-Val-GIn-Trp-Leu-lle-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-NH2
solubility
Easy to dissolve in water
Purity:
≥99%
Name Product:
Tirzepatide
Molecular structural formula
Product 931-184
CAS Number:
2023788-19-2
Molecular Formula:
C225H348N48O68
Molecular Weight:
four thousand eight hundred and thirteen point four five
Indications:
Obesity, type ll diabetes.
Pharmacology:
GIP is a hormone that can supplement the action of GLP-1 receptor agonists. In preclinical models, GIP has been shown to reduce food intake and increase energy expenditure, leading to weight loss, and when used in combination with GLP-1 receptor agonists, may have a greater impact on metabolic dysregulation markers such as weight, glucose, and lipids.
Route of administration
subcutaneous injection
Taboo Taboo:
Tirzepatide is not suitable for patients with medullary thyroid cancer
Amino Acid Sequence:
Tyr- {Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-lle-{Aib}Leu-Asp-Lys-lle-Ala-GIn- {diacid-C20-γ-Glu-(AEEA)2-Lys}-Ala-Phe-Val-GIn-Trp-Leu-lle-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-NH2
solubility
Easy to dissolve in water
Purity:
≥99%